VKTX financials
Viking Therapeutics (VKTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
VKTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$431.00K | -$393.34M | -$359.64M | -3.19 |
| 2024 | $0.00 | $0.00 | -$150.92M | -$109.96M | -1.01 |
| 2023 | $0.00 | $0.00 | -$100.83M | -$85.89M | -0.91 |
| 2022 | $0.00 | $0.00 | -$70.36M | -$68.87M | -0.88 |
| 2021 | $0.00 | $0.00 | -$55.68M | -$54.99M | -0.70 |
| 2020 | $0.00 | $0.00 | -$42.66M | -$39.49M | -0.50 |